CX-691

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

1999

CX-516, an AMPA modulator from Cortex Pharmaceuticals, is in phase I/IIa clinical trials for the symptomatic treatment of… (More)

Is this relevant?